| Not Yet Recruiting | Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors NCT07472348 | ASST Fatebenefratelli Sacco | — |
| Not Yet Recruiting | Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women NCT07069582 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1 |
| Recruiting | Window Prophylaxis for Pediatric Tuberculosis Prevention Trial NCT07086820 | Pontificia Universidad Catolica de Chile | N/A |
| Not Yet Recruiting | 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam NCT06191692 | Freundeskreis Für Internationale Tuberkulosehilfe e.V | Phase 3 |
| Recruiting | Effects of Tuberculosis Infection on Development and Function of the Placenta NCT06352970 | Lund University | — |
| Suspended | BCG Revaccination in Children and Adolescents NCT05330884 | Tuberculosis Research Centre, India | Phase 3 |
| Active Not Recruiting | Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs NCT06539455 | Stefania Cheli | — |
| Active Not Recruiting | Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharma NCT05122026 | The Aurum Institute NPC | Phase 1 / Phase 2 |
| Recruiting | Testing Health Workers At Risk to Advance Our Understanding of TB Infection NCT06221488 | Beth Israel Deaconess Medical Center | — |
| Active Not Recruiting | Short-course Regimens for the Treatment of Pulmonary Tuberculosis NCT05766267 | Centers for Disease Control and Prevention | Phase 2 / Phase 3 |
| Recruiting | Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service NCT05342064 | Baylor College of Medicine | N/A |
| Recruiting | Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin NCT05069688 | Brigham and Women's Hospital | Phase 1 |
| Completed | Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Age NCT05945498 | Tatyana Zubkova | Phase 1 |
| Unknown | Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City NCT05685641 | National Institute of Respiratory Diseases, Mexico | N/A |
| Completed | Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention NCT05413551 | Stanford University | Phase 1 |
| Recruiting | Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age NCT06289660 | Meyer Children's Hospital IRCCS | — |
| Completed | Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Viro NCT05268380 | University of Namibia | — |
| Completed | Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection NCT05236452 | Bahir Dar University | N/A |
| Recruiting | Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy NCT05443178 | University of Zurich | Phase 1 |
| Terminated | Immunization With BCG Vaccine to Prevent Tuberculosis Infection NCT04453293 | Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 3 |
| Recruiting | Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students NCT05756582 | Eleonora Nucera | — |
| Completed | Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial NCT04494516 | Johns Hopkins University | — |
| Unknown | Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis NCT04575519 | Fundació Institut Germans Trias i Pujol | Phase 2 |
| Unknown | Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB) NCT04988984 | Asan Medical Center | — |
| Completed | Computer Aided Screening for Tuberculosis in Low Resource Environments NCT04545164 | London School of Hygiene and Tropical Medicine | N/A |
| Recruiting | Immunological Biomarkers in Tuberculosis Management NCT04271397 | Hospices Civils de Lyon | N/A |
| Unknown | Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis NCT04148053 | Tongji University | — |
| Withdrawn | A Phase II Study of H56:IC31 in Healthy Adolescents NCT03265977 | Aeras | Phase 2 |
| Completed | COPD Co-infection With Tuberculosis on Th17 Cell Differentiation NCT04966052 | Peking University Third Hospital | — |
| Unknown | Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients NCT03941210 | ANRS, Emerging Infectious Diseases | — |
| Unknown | Tuberculosis In Children Visiting Friends and Relatives NCT04236765 | Hospital Mutua de Terrassa | N/A |
| Completed | Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis NCT02175849 | Oxford University Clinical Research Unit, Vietnam | — |
| Unknown | Equivalence Study of Specificity of PPD NCT01798095 | JHP Pharmaceuticals LLC | Phase 2 |
| Unknown | European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol NCT04677842 | PENTA Foundation | — |
| Unknown | Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose) NCT01689831 | JHP Pharmaceuticals LLC | Phase 2 |
| Completed | Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture NCT01434758 | Oxford University Clinical Research Unit, Vietnam | — |